-The Business Standard Drugs are unaffordable, but price control is the wrong answer There is little doubt that medicines in India are too expensive for most of the population. For the poorest 20 per cent of Indians, the expenditure on medicines alone is 85 per cent of what they spend on their health, according to the National Sample Survey. A World Bank study on the subject found that just out-of-pocket medical costs...
More »SEARCH RESULT
EU fines Ranbaxy, others for blocking cheaper drugs
-Reuters BRUSSELS: Nine drugmakers, including Denmark's Lundbeck and India's Ranbaxy, were fined a total of 146 million euros by EU antitrust regulators on Wednesday for blocking the supply of a cheaper anti-depressant medicine to the market. The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. The EU action came two days...
More »Spectre of drug shortage over TB treatment -Rupali Mukherjee
-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...
More »Rain rage wrecks hill states
-The Telegraph At least 50 people have died in rain-triggered landslides, house collapses and flash floods in the north, mostly in Uttarakhand that has halted the popular Badrinath pilgrimage with around 30,000 pilgrims, many from Bengal, stranded. Three days of incessant rain have sent into spate Uttarakhand rivers that have burst banks and washed away houses - one of them a four-storey structure that had been vacated, apart from a temple. At least...
More »Prices of key drugs to be cut by up to half-Sushmi Dey
-The Business Standard NPPA to soon notify prices in line with new Pharma pricing policy Some key cancer drugs, antibiotics and medicines to treat cardiovascular diseases and tuberculosis are set to become cheaper by up to 50 per cent within the next 45 days. The National Pharmaceutical Pricing Authority (NPPA) will soon notify prices of as many as 150 packs of essential medicines in line with the new Pharma pricing policy, according...
More »